<DOC>
	<DOCNO>NCT01562639</DOCNO>
	<brief_summary>The purpose study collect follow data patient give Nexium capsule ( Nexium ) usual post-marketing use maintenance therapy repeatedly recurring/relapsing reflux oesophagitis .</brief_summary>
	<brief_title>Nexium Capsules RE Maintenance Specific Clinical Experience Investigation</brief_title>
	<detailed_description>Nexium capsule Specific Clinical Experience Investigation Maintenance Therapy Repeatedly Recurring/Relapsing Reflux Oesophagitis</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients repeatedly recurring/relapsing reflux oesophagitis give Nexium first time maintenance therapy . Patients reflux oesophagitis Nexium start ( Grade A , Grade B , Grade C Grade D Los Angeles Classification ( Hoshihara 's modification ) endoscopy ) Patients previous history maintenance therapy repeatedly recurring/ relapse reflux oesophagitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>maintenance therapy ,</keyword>
	<keyword>repeatedly recur ,</keyword>
	<keyword>relapse reflux oesophagitis ,</keyword>
	<keyword>Nexium</keyword>
</DOC>